Smith Kevin Raymond Merrill's Form 4 filing
Inogen IncINGN · filed Mar 4, 2025
- Accession no.
- 0000950170-25-032638
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market purchases total $100.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Kevin Raymond MerrillCIK 0001802639 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Common Stock | AGrant or awardAcquired | +1,500 | $8.33 | +$12,495 | 16,054 | Direct | |
| Mar 1, 2025 | Common Stock | MOption exerciseAcquired | +28,333 | $0.00 | $0 | 44,387 | Direct | |
| Mar 1, 2025 | Common Stock | FTax withholdingDisposed | −13,700 | $8.33 | −$114,121 | 30,687 | Direct | |
| Mar 1, 2025 | Common Stock | AGrant or awardAcquired | +53,975 | $0.00 | $0 | 84,662 | Direct | |
| Mar 1, 2025 | Common Stock | FTax withholdingDisposed | −26,097 | $8.33 | −$217,388.01 | 58,565 | Direct | |
| Mar 3, 2025 | Common Stock | PPurchaseAcquired | +11,709 | $8.56F5 | +$100,229.04 | 70,274 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | AGrant or awardAcquired | +90,036 | $0.00 | $0 | 90,036 | Direct | |
| Mar 1, 2025 | Common Stock | MOption exerciseDisposed | −28,333 | $0.00 | $0 | 56,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
Represents the weighted average share price of an aggregate total of 11,709 shares sold in the price range of $8.455 to $8.6298 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.